| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | -23 | 85 | -0.17 | -2.19 | BLENDED GS |
| May 2025 | 25 | 86 | -2.85 | -0.84 | BLENDED GS |
| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | -23 | 85 | -0.17 | -2.19 | BLENDED GS |
| May 2025 | 25 | 86 | -2.85 | -0.84 | BLENDED GS |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 353 | 135 | BLENDED GS |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 135 | 353 | 5464 | 380 | 385 | 86 | 86 |
| May 2025 | 135 | 351 | 5452 | 379 | 385 | 86 | 86 |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 135 | 353 | 5464 | 380 | 385 | 86 | 86 |
| May 2025 | 135 | 351 | 5452 | 379 | 385 | 86 | 86 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 338 | 291 | 215 | 179 | 138 |
| No. Herds | 121 | 120 | 107 | 91 | 75 |
| No. without completed record | 2 | 5 | 4 | 1 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 338 | 291 | 215 | 179 | 138 |
| No. Herds | 121 | 120 | 107 | 91 | 75 |
| No. without completed record | 2 | 5 | 4 | 1 |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 353 | 135 | BLENDED GS |
| Country | Fertility | Survival | ||
|---|---|---|---|---|
| Daughters | Herds | Daughters | Herds | |
| AUS | 0 | 0 | 0 | 0 |
| CAN | 0 | 0 | 0 | 0 |
| DFS | 0 | 0 | 0 | 0 |
| FRA | 0 | 0 | 0 | 0 |
| GBR | 99 | 18 | 136 | 24 |
| GER | 0 | 0 | 0 | 0 |
| ITA | 0 | 0 | 0 | 0 |
| NLD | 0 | 0 | 0 | 0 |
| NZL | 0 | 0 | 0 | 0 |
| USA | 0 | 0 | 0 | 0 |